Literature DB >> 12565905

Homozygous deletions and point mutations of the Rit1/Bcl11b gene in gamma-ray induced mouse thymic lymphomas.

Yuichi Wakabayashi1, Jun Inoue, Yoshiaki Takahashi, Atsushi Matsuki, Hitomi Kosugi-Okano, Toshimitsu Shinbo, Yukio Mishima, Ohtsura Niwa, Ryo Kominami.   

Abstract

Allelic loss (LOH) mapping and sequence analysis were conducted for gamma-ray induced mouse thymic lymphomas and a novel tumor suppressor gene, Rit1/Bcl11b, on chromosome 12 was isolated. Bi-allelic changes were found in 17 of the 66 p53-proficient lymphomas with Rit1 LOH but in only 2 of the 54 p53-deficient lymphomas. This suggests an association between the presence of functional p53 and inactivation of the Rit1 gene in the lymphoma development. Introduction of Rit1 into HeLa cells lacking Rit1 expression suppressed cell growth. These results indicate that loss-of-function mutations of Rit1 contribute to mouse lymphomagenesis and possibly to human cancer development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12565905     DOI: 10.1016/s0006-291x(02)03069-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  44 in total

1.  CTIP1 and CTIP2 are differentially expressed during mouse embryogenesis.

Authors:  Mark Leid; Jane E Ishmael; Dorina Avram; David Shepherd; Valérie Fraulob; Pascal Dollé
Journal:  Gene Expr Patterns       Date:  2004-10       Impact factor: 1.224

2.  Bcl11b/Ctip2 controls the differentiation of vomeronasal sensory neurons in mice.

Authors:  Takayuki Enomoto; Makoto Ohmoto; Tetsuo Iwata; Ayako Uno; Masato Saitou; Tatsuya Yamaguchi; Ryo Kominami; Ichiro Matsumoto; Junji Hirota
Journal:  J Neurosci       Date:  2011-07-13       Impact factor: 6.167

3.  Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease.

Authors:  Paula A Desplats; James R Lambert; Elizabeth A Thomas
Journal:  Neurobiol Dis       Date:  2008-05-22       Impact factor: 5.996

4.  Protein Kinase C-Mediated Phosphorylation of BCL11B at Serine 2 Negatively Regulates Its Interaction with NuRD Complexes during CD4+ T-Cell Activation.

Authors:  Marion Dubuissez; Ingrid Loison; Sonia Paget; Han Vorng; Saliha Ait-Yahia; Olivier Rohr; Anne Tsicopoulos; Dominique Leprince
Journal:  Mol Cell Biol       Date:  2016-06-15       Impact factor: 4.272

5.  BCL11B participates in the activation of IL2 gene expression in CD4+ T lymphocytes.

Authors:  Valeriu B Cismasiu; Sailaja Ghanta; Javier Duque; Diana I Albu; Hong-Mei Chen; Rohini Kasturi; Dorina Avram
Journal:  Blood       Date:  2006-06-29       Impact factor: 22.113

Review 6.  The multifaceted roles of Bcl11b in thymic and peripheral T cells: impact on immune diseases.

Authors:  Dorina Avram; Danielle Califano
Journal:  J Immunol       Date:  2014-09-01       Impact factor: 5.422

7.  Involvement of the histone deacetylase SIRT1 in chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2-mediated transcriptional repression.

Authors:  Thanaset Senawong; Valerie J Peterson; Dorina Avram; David M Shepherd; Roy A Frye; Saverio Minucci; Mark Leid
Journal:  J Biol Chem       Date:  2003-08-19       Impact factor: 5.157

8.  Antigen-specific clonal expansion and cytolytic effector function of CD8+ T lymphocytes depend on the transcription factor Bcl11b.

Authors:  Shuning Zhang; Mike Rozell; Raj K Verma; Diana I Albu; Danielle Califano; Jeffrey VanValkenburgh; Akeel Merchant; Javier Rangel-Moreno; Troy D Randall; Nancy A Jenkins; Neal G Copeland; Pentao Liu; Dorina Avram
Journal:  J Exp Med       Date:  2010-07-26       Impact factor: 14.307

9.  Increased expression of bcl11b leads to chemoresistance accompanied by G1 accumulation.

Authors:  Piotr Grabarczyk; Viola Nähse; Martin Delin; Grzegorz Przybylski; Maren Depke; Petra Hildebrandt; Uwe Völker; Christian A Schmidt
Journal:  PLoS One       Date:  2010-09-02       Impact factor: 3.240

10.  BCL11B is a general transcriptional repressor of the HIV-1 long terminal repeat in T lymphocytes through recruitment of the NuRD complex.

Authors:  Valeriu B Cismasiu; Elena Paskaleva; Sneha Suman Daya; Mario Canki; Karen Duus; Dorina Avram
Journal:  Virology       Date:  2008-09-02       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.